ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,235.48
-0.60%
US Tech 100
18,051.20
-1.13%
Dow Jones
38,111.48
-0.86%
Brent Oil
81.90
-1.77%
Bitcoin
68,487.99
1.33%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/30/20244:53PMBusiness WireAirgain signe un protocole d'accord stratégique avec COMPAL, un des leaders mondiaux du Fortune 500, sur la technologie 5G Smart FWA d'AirgainNASDAQ:AIRGAirgain Inc
05/30/20244:53PMBusiness WireKBRA Assigns Preliminary Ratings to SCF Equipment Leasing 2024-1
05/30/20244:52PMPR Newswire (Canada)LYB élargit ses activités de base de PP avec une participation de 35 % dans la NATPET d'Alujain en Arabie saouditeNYSE:LYBLyondellBasell Industries NV
05/30/20244:51PMGlobeNewswire Inc.Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALSNASDAQ:BIIBBiogen Inc
05/30/20244:51PMGlobeNewswire Inc.Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALSTG:IDPBiogen Inc
05/30/20244:51PMGlobeNewswire Inc.Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALSLSE:0R1BBiogen Inc
05/30/20244:51PMGlobeNewswire Inc.Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALSBIT:1BIIBBiogen Inc
05/30/20244:51PMGlobeNewswire Inc.Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALSXE:IDPBiogen Inc
05/30/20244:51PMGlobeNewswire Inc.BurgerFi to Consider Strategic AlternativesNASDAQ:BFIIWBurgerFi International Inc
05/30/20244:51PMGlobeNewswire Inc.BurgerFi to Consider Strategic AlternativesNASDAQ:BFIBurgerFi International Inc
05/30/20244:51PMBusiness WireMarcus Theatres Rolls out New, “Everyday Matinee”-- $7 Tickets for Seniors and Kids!NYSE:MCSMarcus Corp
05/30/20244:50PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
05/30/20244:50PMGlobeNewswire Inc.BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing StandardsAMEX:PHGEBiomX Inc
05/30/20244:50PMPR Newswire (US)X Financial Reports First Quarter 2024 Unaudited Financial ResultsNYSE:XYFX Financial
05/30/20244:50PMPR Newswire (Canada)Phase finale des travaux au parc D'Argenson : de l'entraînement de rue pour les ados, un parc canin et une ancienne rivière évoquée
05/30/20244:49PMAlliance NewsAlliance NewsTrump trial jury issues note saying it has reached verdict
05/30/20244:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BANDBandwidth Inc
05/30/20244:49PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
05/30/20244:49PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:WTIW and T Offshore Inc
05/30/20244:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BBGIBeasley Broadcast Group Inc
05/30/20244:49PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
05/30/20244:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTXMeiraGTx Holdings PLC
05/30/20244:48PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXZiPath Series B S&P 500 VIX MidTerm Futures ETN
05/30/20244:48PMEdgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingUSOTC:SMTKDSmartKem Inc (QB)
05/30/20244:48PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
05/30/20244:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BANDBandwidth Inc
05/30/20244:48PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:CCitigroup Inc
05/30/20244:48PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDUCEducational Development Corporation
05/30/20244:48PMPR Newswire (US)Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®NASDAQ:VNDAVanda Pharmaceuticals Inc
05/30/20244:48PMPR Newswire (Canada)Le Musée canadien de la guerre souligne le 80e anniversaire du jour J avec une exposition et des programmes

Your Recent History

USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
BLEG
Branded Legacy (PK)
USOTC
EPAZ
Epazz (PK)
USOTC
KEGS
1812 Brewing (PK)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
SPZI
Spooz (PK)
USOTC
GRLT
Grillit (PK)
USOTC
AFFU
Affluence (PK)
USOTC
AHRO
Authentic (CE)
NASDAQ
AGBA
AGBA
USOTC
ENZC
Enzolytics (PK)
NASDAQ
RNAZ
TransCode Therapeutics
USOTC
ASKH
Astika (PK)
USOTC
NSAV
Net Savings Link (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved